Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 11/15/21 (What's New)


  • 5-year survival rate for persons with HIV and invasive anal cancer earlier in HAART era: 47%[Bower 2004]
    • Later HAART era study demonstrated 70% 5-year OS rate in persons with HIV with invasive anal canal cancer vs 69% in matched controls[Oehler-Jänne 2006]
    • OS negatively associated with high HIV-1 RNA level and low CD4+ cell count

Action required